1
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
Condition(s):Ductal Breast Carcinoma in Situ; Estrogen Receptor-positive Breast CancerLast Updated:July 21, 2015Completed
Ductal Breast Carcinoma In Situ: 314 Clinical Trials, Page 1 of 32
Hide Studies Not Open or Pending
2
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
Condition(s):Ductal Breast Carcinoma In Situ; HER2/Neu PositiveLast Updated:April 20, 2018Completed
3
Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Condition(s):Ductal Breast Carcinoma in SituLast Updated:February 6, 2020Recruiting
4
Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast
Condition(s):Intraductal Carcinoma and Lobular Carcinoma in SituLast Updated:August 25, 2016Completed
5
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
Condition(s):Breast CancerLast Updated:April 14, 2020Recruiting
6
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Condition(s):Breast CancerLast Updated:May 17, 2017Completed
7
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Condition(s):Breast CancerLast Updated:December 4, 2020Completed
8
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Condition(s):Ductal Carcinoma in SituLast Updated:April 9, 2020Terminated
9
Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Condition(s):Breast CancerLast Updated:February 25, 2013Terminated
10
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Condition(s):Breast CancerLast Updated:November 21, 2014Completed